Trends of tea in cardiovascular health and disease: A critical review
Authors:
- Jian FangJFJian Fang
- Antoni SuredaAntoni Sureda
- Ana Sanches SilvaAna Sanches Silva
- Fazlullah KhanFazlullah Khan
- Suowen XuSuowen Xu
- Seyed Mohammed NabaviSNSeyed Mohammed Nabavi
- 1 June 2019
- journal article
- review article
- Published by Elsevier in Trends in Food Science & Technology
- Vol. 88, 385-396
Abstract
No abstract availableKeywords
Funding Information
- Programme of Promotion of Biomedical Research and Health Sciences
- CIBERobn (CB12/03/30038)
- Career Development Award from American Heart Association (18CDA34110359)
This publication has 126 references indexed in Scilit:
- Antioxidant activity of white, green and black tea obtained from the same tea cultivarFood Research International, 2013
- Tea and human health: The dark shadowsToxicology Letters, 2013
- The Effect of Green Tea and Sour Tea on Blood Pressure of Patients with Type 2 Diabetes: A Randomized Clinical TrialJournal of Dietary Supplements, 2013
- Green tea: A boon for periodontal and general healthJournal of Indian Society of Periodontology, 2012
- Tea and cardiovascular diseasePharmacological Research, 2011
- Inhibitory effects of epigallocatechin-3-O-gallate on serum-stimulated rat aortic smooth muscle cells via nuclear factor-κB down-modulationBiochemical and Biophysical Research Communications, 2006
- Upregulation of heme oxygenase-1 by Epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathwaysLife Sciences, 2006
- Differential Effects of Green Tea–Derived Catechin on Developing Versus Established Atherosclerosis in Apolipoprotein E–Null MiceCirculation, 2004
- The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cellsBiochemical and Biophysical Research Communications, 2004
- Tea flavonoids and cardiovascular diseases: A reviewCritical Reviews in Food Science and Nutrition, 1997